Literature DB >> 17178734

Hyponatraemia in adults with community-acquired bacterial meningitis.

M C Brouwer1, D van de Beek, S G B Heckenberg, L Spanjaard, J de Gans.   

Abstract

BACKGROUND: Hyponatraemia in adults with bacterial meningitis has been described as a common complication, but its true prevalence and clinical importance are unknown. AIM: To investigate the prevalence, clinical characteristics and consequences of hyponatraemia in bacterial meningitis in adults.
DESIGN: Nationwide observational cohort study.
METHODS: We prospectively assessed the prevalence and clinical characteristics of hyponatraemia among 696 adults with community-acquired bacterial meningitis. Symptoms and signs on admission, blood and CSF test results, radiological examinations and complications during admission were recorded.
RESULTS: Sodium levels were determined at admission in 685/696 episodes of bacterial meningitis (98%). Hyponatraemia (<135 mmol/l) was seen in 208/685 (30%) and was classified as severe (<130 mmol/l) in 38 (6%). Hyponatraemia developed during admission in an additional 53 episodes. Hyponatraemia was not associated with an increase in symptoms, with complications or with unfavourable outcome. Treatment for hyponatraemia was initiated in 16% of episodes, but did not influence its duration. DISCUSSION: Hyponatraemia appears both common and benign in adults with bacterial meningitis. In cases of severe hyponatraemia, we suggest the use of fluid maintenance therapy.

Entities:  

Mesh:

Year:  2006        PMID: 17178734     DOI: 10.1093/qjmed/hcl131

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  Understanding coma in bacterial meningitis.

Authors:  R Sonneville; G Citerio; G Meyfroidt
Journal:  Intensive Care Med       Date:  2015-09-28       Impact factor: 17.440

2.  Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults.

Authors:  Rosario Amaya-Villar; Emilio García-Cabrera; Elena Sulleiro-Igual; Pedro Fernández-Viladrich; Dionisi Fontanals-Aymerich; Pilar Catalán-Alonso; Carlos Rodrigo-Gonzalo de Liria; Ana Coloma-Conde; Fabio Grill-Díaz; Antonio Guerrero-Espejo; Jerónimo Pachón; Guillén Prats-Pastor
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

3.  Hyponatremia is a potential predictor of progression in radiation-induced brain necrosis: a retrospective study.

Authors:  Huan Liao; Zhuoting Zhu; Xiaoming Rong; Hongxuan Wang; Ying Peng
Journal:  BMC Neurol       Date:  2018-08-29       Impact factor: 2.474

4.  Listeria Monocytogenes Meningitis in an Immunocompetent Patient.

Authors:  Oana Magiar; Silvana Vulpie; Corina Musuroi; Iosif Marincu; Alina Murariu; Mirela Turaiche; Silvia Ioana Musuroi; Delia Muntean; Monica Licker
Journal:  Infect Drug Resist       Date:  2022-03-10       Impact factor: 4.003

5.  Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study.

Authors:  Marya D Zilberberg; Alex Exuzides; James Spalding; Aimee Foreman; Alison Graves Jones; Chris Colby; Andrew F Shorr
Journal:  BMC Pulm Med       Date:  2008-08-18       Impact factor: 3.317

6.  Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center.

Authors:  Sean M Barber; Brandon D Liebelt; David S Baskin
Journal:  J Clin Med       Date:  2014-10-28       Impact factor: 4.241

7.  High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi.

Authors:  Emma C Wall; Katharine Cartwright; Matthew Scarborough; Katherine M Ajdukiewicz; Patrick Goodson; James Mwambene; Eduard E Zijlstra; Stephen B Gordon; Neil French; Brian Faragher; Robert S Heyderman; David G Lalloo
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

8.  A Cross-Sectional Study of Hyponatremia Associated with Acute Central Nervous System Infections.

Authors:  Andy K H Lim; Sahira Paramaswaran; Lucy J Jellie; Ralph K Junckerstorff
Journal:  J Clin Med       Date:  2019-10-27       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.